awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q57483927-0B8E11BD-9A8F-4F57-9B06-ADC0084202F0
Q57483927-0B8E11BD-9A8F-4F57-9B06-ADC0084202F0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q57483927-0B8E11BD-9A8F-4F57-9B06-ADC0084202F0
Pembrolizumab for the treatment of patients with recurrent locally advanced or metastatic gastric or gastroesophageal junction cancer: an evidence-based review of place in therapy
P2860
Q57483927-0B8E11BD-9A8F-4F57-9B06-ADC0084202F0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q57483927-0B8E11BD-9A8F-4F57-9B06-ADC0084202F0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1a8e594dead1898702dc6158bbac0aca6e035d13
P2860
Cost Effectiveness of Pembrolizumab vs. Standard-of-Care Chemotherapy as First-Line Treatment for Metastatic NSCLC that Expresses High Levels of PD-L1 in the United States.